1. Home
  2. GKOS vs ADC Comparison

GKOS vs ADC Comparison

Compare GKOS & ADC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$238.12

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo Agree Realty Corporation

ADC

Agree Realty Corporation

N/A

Current Price

$70.18

Market Cap

8.0B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
ADC
Founded
1998
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.0B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
GKOS
ADC
Price
$238.12
$70.18
Analyst Decision
Strong Buy
Buy
Analyst Count
13
20
Target Price
★ $243.85
$77.86
AVG Volume (30 Days)
★ 1.5M
1.4M
Earning Date
10-28-2026
10-20-2026
Dividend Yield
N/A
★ 4.63%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 1.47
Revenue
$507,442,000.00
★ $718,398,000.00
Revenue This Year
$53.82
$16.93
Revenue Next Year
$28.56
$12.82
P/E Ratio
★ N/A
$47.32
Revenue Growth
★ 32.33
16.42
52 Week Low
$93.78
$64.34
52 Week High
$255.19
$82.08

Technical Indicators

Market Signals
Indicator
GKOS
ADC
Relative Strength Index (RSI) 59.90 58.33
Support Level $147.72 $64.38
Resistance Level $255.19 $70.91
Average True Range (ATR) 11.84 1.15
MACD -1.49 0.09
Stochastic Oscillator 43.31 77.85

Price Performance

Historical Comparison
GKOS
ADC

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About ADC Agree Realty Corporation

Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.

Share on Social Networks: